Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Histamine H2 Antagonists
×
Clear all
Filters
2
NCT06305754
2026-03-13
MK-2870-009
Merck Sharp & Dohme LLC
Phase 3
Recruiting
520 enrolled
NCT06824467
2026-03-13
TroFuse-022
Merck Sharp & Dohme LLC
Phase 3
Recruiting
770 enrolled